Running Ahead of the Pack in Technology Development
Executive SummaryDevice companies have historically kept innovation simple, giving doctors new tools that look and feel very much like what they've used in the past. But what happens when device innovation runs ahead of customers' willingness to adopt new technology?
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.